Celltrion

Celltrion Equity

The The Equity of Celltrion (068270.KS) as of Nov 18, 2026 is 17.21 T KRW. In the previous year, The Equity was 17.44 T KRW — a change of -1.32% (lower).

Equity

17.21 TKRW

YoY

-1.32%

Last updated:

In 2025, Celltrion's equity was 17.21 T KRW, a -1.32% increase from the 17.44 T KRW equity in the previous year.

The Celltrion Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
2.49 T KRW
Jan 1, 2019
2.76 T KRW
Jan 1, 2020
3.31 T KRW
Jan 1, 2021
3.92 T KRW
Jan 1, 2022
4.14 T KRW
Jan 1, 2023
16.98 T KRW
Jan 1, 2024
17.44 T KRW
Jan 1, 2025
17.21 T KRW
The Celltrion Equity history
YEAREquityYoY
17.21 TKRW-1.32%
17.44 TKRW+2.70%
16.98 TKRW+310.22%
4.14 TKRW+5.67%
3.92 TKRW+18.43%
3.31 TKRW+19.84%
2.76 TKRW+11.00%
2.49 TKRW+8.70%
2.29 TKRW+11.39%
2.05 TKRW+21.21%
1.69 TKRW+35.82%
1.25 TKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celltrion Stock analysis

What does Celltrion do? Celltrion Inc is a South Korean company that was founded in 2002 and specializes in the development and manufacturing of biopharmaceutical products. The company is headquartered in Incheon, South Korea and employs over 2,000 people worldwide. Celltrion is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Celltrion's Equity

Celltrion's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Celltrion's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Celltrion's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Celltrion's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Celltrion’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Celltrion stock

The Equity of Celltrion is 17.21 T KRW in 2025.

The Equity of Celltrion changed from 17.44 T KRW to 17.21 T KRW, representing a -1.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Celltrion since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Celltrion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Celltrion

All Key Metrics — Celltrion